InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Brett R Hagen, Chief Accounting Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 46 open-market SEC Form 4 transactions: 0 purchases worth $0 and 46 sales worth $442K, reported from Jan 20, 22 to Mar 20, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 26 | KLRSKalaris Therapeutics, Inc. | SELL | 1.9K | $6.72 | $13K |
| Mar 26, 25 | KLRSKalaris Therapeutics, Inc. | SELL | 907 | $8.97 | $8K |
| Feb 21, 25 | ALVRAllovir, Inc. | SELL | 96 | $10.08 | $968 |
| Jan 23, 25 | ALVRAllovir, Inc. | SELL | 32 | $9.94 | $302 |
| Jan 10, 25 | ALVRAllovir, Inc. | SELL | 332 | $0.44 | $146 |
| Nov 19, 24 | ALVRAllovir, Inc. | SELL | 554 | $0.55 | $305 |
| Nov 5, 24 | ALVRAllovir, Inc. | SELL | 1.7K | $0.86 | $1K |
| Oct 22, 24 | ALVRAllovir, Inc. | SELL | 486 | $0.77 | $374 |
| Oct 21, 24 | ALVRAllovir, Inc. | SELL | 479 | $0.78 | $374 |
| Oct 3, 24 | ALVRAllovir, Inc. | SELL | 301 | $0.81 | $244 |
| Aug 19, 24 | ALVRAllovir, Inc. | SELL | 544 | $0.76 | $413 |
| Aug 5, 24 | ALVRAllovir, Inc. | SELL | 1.7K | $0.73 | $1K |
| Jul 22, 24 | ALVRAllovir, Inc. | SELL | 481 | $0.74 | $356 |
| Jul 19, 24 | ALVRAllovir, Inc. | SELL | 479 | $0.75 | $359 |
| Jul 2, 24 | ALVRAllovir, Inc. | SELL | 304 | $0.72 | $219 |
| May 17, 24 | ALVRAllovir, Inc. | SELL | 541 | $0.75 | $406 |
| May 3, 24 | ALVRAllovir, Inc. | SELL | 1.6K | $0.80 | $1K |
| Apr 22, 24 | ALVRAllovir, Inc. | SELL | 480 | $0.75 | $360 |
| Apr 19, 24 | ALVRAllovir, Inc. | SELL | 473 | $0.75 | $355 |
| Apr 2, 24 | ALVRAllovir, Inc. | SELL | 281 | $0.77 | $216 |
| Feb 20, 24 | ALVRAllovir, Inc. | SELL | 494 | $0.70 | $346 |
| Feb 8, 24 | ALVRAllovir, Inc. | SELL | 11.2K | $0.67 | $7K |
| Feb 5, 24 | ALVRAllovir, Inc. | SELL | 5.8K | $0.67 | $4K |
| Jan 23, 24 | ALVRAllovir, Inc. | SELL | 901 | $0.67 | $604 |
| Jan 4, 24 | ALVRAllovir, Inc. | SELL | 310 | $0.64 | $198 |
| Dec 27, 23 | ALVRAllovir, Inc. | SELL | 28.3K | $0.74 | $21K |
| Nov 17, 23 | ALVRAllovir, Inc. | SELL | 403 | $1.63 | $657 |
| Oct 20, 23 | ALVRAllovir, Inc. | SELL | 357 | $1.54 | $550 |
| Oct 19, 23 | ALVRAllovir, Inc. | SELL | 358 | $1.58 | $566 |
| Oct 3, 23 | ALVRAllovir, Inc. | SELL | 222 | $1.98 | $440 |
| Aug 17, 23 | ALVRAllovir, Inc. | SELL | 1.7K | $2.50 | $4K |
| Jul 20, 23 | ALVRAllovir, Inc. | SELL | 342 | $3.35 | $1K |
| Jul 19, 23 | ALVRAllovir, Inc. | SELL | 342 | $3.56 | $1K |
| Jun 9, 23 | ALVRAllovir, Inc. | SELL | 5.0K | $5.64 | $28K |
| Apr 20, 23 | ALVRAllovir, Inc. | SELL | 349 | $3.63 | $1K |
| Apr 19, 23 | ALVRAllovir, Inc. | SELL | 348 | $3.71 | $1K |
| Jan 20, 23 | ALVRAllovir, Inc. | SELL | 338 | $5.14 | $2K |
| Jan 19, 23 | ALVRAllovir, Inc. | SELL | 1.6K | $5.08 | $8K |
| Nov 11, 22 | ALVRAllovir, Inc. | SELL | 18.0K | $8.18 | $147K |
| Nov 10, 22 | ALVRAllovir, Inc. | SELL | 6.0K | $8.00 | $48K |
| Oct 24, 22 | ALVRAllovir, Inc. | SELL | 2.0K | $8.13 | $16K |
| Oct 21, 22 | ALVRAllovir, Inc. | SELL | 11.3K | $8.45 | $96K |
| Oct 20, 22 | ALVRAllovir, Inc. | SELL | 345 | $9.36 | $3K |
| Oct 19, 22 | ALVRAllovir, Inc. | SELL | 345 | $9.36 | $3K |
| Apr 20, 22 | ALVRAllovir, Inc. | SELL | 276 | $6.68 | $2K |
| Jan 20, 22 | ALVRAllovir, Inc. | SELL | 1.6K | $8.75 | $14K |